2025 年 4 月 – 第 25 頁 – Today in Hong Kong

諾科達AI機器人華麗登場開啟智能教育新場景

04/08/2025

EQS 新聞 via SEAPRWire.com / 2025-04-08 / 10:30 UTC+8 （2025年4月8日 – 香港）諾科達科技集團有限公司（「諾科達」；股份代號：519.HK）旗下AI機器人S2 (「諾科達AI機器人」)，於2025年4月3日正式亮相香港校園揭幕儀式，標誌著諾科達於智能教育場景應用邁向新階段。揭幕儀式由教育局副局長主持，逾百位教育界代表出席典禮。活動期間，諾科達AI機器人憑藉其多元AI交互系統，具備智能問答、精準導覽等核心功能，全程擔任接待工作，並與嘉賓開展各類互動。諾科達AI機器人引領教育局副局長及一眾嘉賓進場香港特別行政區政府高度重視智能教育發展，已將人工智能教育納入《香港創新科技發展藍圖》重點項目。根據2025-26年財政預算案公布，政府將於未來三年（2025-2028年度）額外撥款8億港元，重點推動智能教學設備採購、教師培訓及數據基建升級等工作。隨著政府政策支持及資源投入持續加大，配合本地科技企業之創新能力，香港有望於未來五年內發展成為亞太區智能教育樞紐，進一步鞏固其國際創新科技中心之地位。諾科達AI機器人亦希望通過與政府於教育領域之合作，推動香港智能教育發展。 - 完 - 關於諾科達科技集團有限公司諾科達科技集團有限公司（Novautek Technologies Group Limited）主要業務為自動駕駛、物業發展、物業投資及投資控股。集團於2023年成功設立諾科達智駕，並於2024年設立自動駕駛分部，專注於發展環衛、巡邏、倉儲、物流及運輸等特定場景下自動駕駛技術的相關產品及服務。集團立足香港，除服務本地市場外，亦於全球範圍推廣高科技產品。此新聞稿由金通策略代表諾科達科技集團有限公司發放。 DLK Advisory 金通策略 pr@dlkadvisory.com 電話：+852 2857 7101 傳真：+852 2857 7103 2025-04-08 此財經新聞稿由EQS Group via SEAPRWire.com轉載。本公告內容由發行人全權負責。瀏覽原文: http://www.todayir.com/tc/index.php

SeaPRwire

Taiwanese Artist Grace Tan Fuses Ink, Rhythm, and Light to Create a Cross-Cultural Dialogue

04/08/2025

Taipei, Taiwan – April 08, 2025 – (SeaPRwire) – In a feature recently published by The Icons, Taiwanese artist Grace Tan is recognized for redefining the language of traditional ink art through a contemporary, multi-sensory approach. A master of calligraphy and seal carving, Tan seamlessly blends Eastern aesthetics with Western structures, transforming brush, ink, and rhythm into a vivid cross-cultural dialogue. Rooted in the rich cultural heritage of Taiwan, Grace Tan views art as a universal language – one that speaks beyond technique and form. “Art is the language of the soul,” she explains. “Its power lies in whether it can create a resonance – a rhythm that connects deeply with others.” Her artistic practice is deeply influenced by music, particularly her study of the pipa, a traditional Chinese instrument. She describes her brushwork as a visual form of music, where ink density, stroke pressure, and spatial pauses mirror tempo, pitch, and silence in a musical composition. Her compositions are at once lyrical and structured, poetic yet dynamic. Through innovative techniques such as layering, geometry, and the use of lightboxes, Tan creates an immersive visual-musical experience. Her artworks are not static; they shift in response to lighting and perspective, offering viewers a real-time encounter with rhythm, space, and emotion. As a Taiwanese artist active on the international stage, Grace Tan has exhibited in France, the United States, Japan, and South Korea. Her works are housed in the permanent collections of the World Bank Headquarters, the American Academy of Asian Culture, the San Francisco Public Library, and the University of Cyprus – testament to her growing global impact. Grace Tan composes with ink and lets her lines sing, transforming calligraphy, seal carving, and visual art into vessels of musical expression. From the interplay of geometry and colour, to the rhythmic flow of brushstrokes and the carefully composed cadence within her seal designs, her work reflects a profound exploration of “rhythmic writing.” The dryness or fluidity of ink, the tension and release of each line, and the thoughtful use of negative space resemble the dynamics and pauses found in musical composition – all weaving together into her own distinctive artistic tapestry. (Photography: Grace Tan) Her artistic voice carries particular resonance for European audiences, who appreciate her thoughtful fusion of East and West. By combining the introspective stillness of Eastern philosophy with the expressive freedom of contemporary Western art, she opens a space for cultural reflection and connection. Grace Tan’s work is not just a celebration of tradition, but a reimagining of it – offering a vision of art that transcends borders and speaks to the shared human experience.

Growing Ecommerce 3PL Reports 3x Earnings Growth in 2024 and Forecasts Higher Revenue Growth in the Coming 12 Months

04/08/2025

FARMINGDALE, New York – April 08, 2025 – (SeaPRwire) – Innovative Warehouse Solutions (IWS) successfully shipped over 280,000 units in December 2024, a 300% rise from the 96,000 units of the same month the previous year. This new achievement shows the genuine commitment of IWS to provide excellent fulfillment solutions that help businesses scale better. Behind the Success For ecommerce brands, Q4 determines whether the upcoming year is set for growth. A surge in orders presents opportunities for increased revenue and a new wave of customers. Scaling at this speed can prove challenging both for brands that fulfill in-house and brands that utilize 3PL services. The challenges are mainly related to antiquated systems that require extensive training for new personnel. IWS Solution IWS enables brands to handle not only their standard volume but also allows brands to quickly 10x their brand while delivering the same accuracy and speed. ● Double-Scan Accuracy Process ● Every item passed through two scan points – during picking and packing. ● Every order is additionally visually checked 2 times for accuracy and product quality before shipping. ● Fast Training and State-of-the-Art System ● IWS’s Warehouse Management System (WMS) provides a visual picture of the items and advanced warehouse routing. Ensuring fast processing times and industry-leading accuracy. ● These visual cues and walking paths allow new hires to be trained in hours, not weeks. ● Improved Customer Support ● IWS introduced a live chat system that connects brands directly with the right department – warehouse teams, receiving, shipping, billing, and customer support. ● This new system reduced bottlenecks, improved response time, and allowed a better flow of information. Future Plans: What’s Next for the Industry and IWS Following the success, this E-commerce 3PL company expects continued growth in 2025. The company projects monthly shipments to remain 75-85% higher than last year. The industry’s growth also supports this trajectory. Ecommerce saw a positive increase of 8-9% in 2024, and with more consumers choosing online shopping over traditional retail, new opportunities opened for small and mid-sized brands. This shift, combined with 3PL services like IWS, allows businesses to enter the market without the heavy costs of retail partnerships. The CEO said this in awe. “The team at IWS was blown away by the success of our partners in Q4 2024. There were a lot of early mornings, late nights, and weekends for both IWS and our partners. From a bird’s eye view, it was amazing to watch. Brands working at the speed of light to market and create great content to engage and convert new customers. With the IWS team working at the same speed to fulfill and get those products into the hands of the end users.” He continued, “With a new record year in our rearview, IWS is looking forward to pushing the bar further in 2025. With some exciting new partners already onboarded, we are sure 2025 will be our best year yet.” See how IWS can support your ecommerce growth. Contact Innovative Warehouse Solutions to speak with a fulfillment expert. About Innovative Warehouse Solutions IWS provides secure warehousing, quick fulfillment, and shipping for direct-to-consumer brands. With same-day shipping, predictive tracking, and 99.98% accuracy, IWS helps companies expand with zero downtime. Media contact Brand: Innovative Warehouse Solutions Contact: Media team Email: Info@invwhs.com Website: https://invwhs.com

ACN Newswire

FOURTH PARADIGM ANNOUNCES 2024 ANNUAL RESULTS

04/08/2025

Financial Highlights:- In 2024, the total revenue amounted to RMB5,261 million, representing a YoY increase of 25.1% - The revenue of the 4Paradigm Sage AI Platform (the “Sage AI Platform”) business grew by 46.7% YoY to RMB3,676 million, accounting for 69.9% of the total revenue - The SHIFT Intelligent Solutions business recorded revenue of RMB1,022 million, accounting for 19.4% of the total revenue - The revenue of the 4Paradigm SageGPT AIGS Services segment amounted to RMB563 million, accounting for 10.7% of the total revenue- Gross profit was RMB2,245 million, with a gross profit margin of 42.7%- The total R&D expenses reached RMB2,170 million, accounting for 41.2% of revenue- The annual loss attributable to the owners of the Company was RMB269 million, with a reduction of RMB640 million compared to the full year of 2023, narrowing by 70.4% YoY. This marks the fourth consecutive fiscal year of sequential loss reduction since 2021Operation Highlights:- In 2024, the number of lighthouse users served by the Company reached 161, a YoY increase of 16%. The average revenue per lighthouse user was RMB19 million, with a Net Dollar Expansion Rate (NDER) of 110% for lighthouse users in 2024- 4ParadigmSage: During the Reporting Period, the Company launched the vertical world model development and management platform, Sage AI Platform 5.0, and completed multiple minor version upgrades, achieving end-to-end capabilities across the computing layer, platform layer, model layer, and application layer- 4Paradigm SHIFT: During the Reporting Period, the Company launched multiple solutions targeting various application scenarios and continued to update and iterate the functionalities and effectiveness of existing solutions to meet enterprise requirements for accuracy, reliability, and real-time performance in different vertical scenarios- 4Paradigm AIGS: During the Reporting Period, the Company continued to upgrade and optimize the functionality and application performance of products, such as the enterprise software reconfiguration assistant AIGS Builder and the enterprise programming assistant AIGS CodeX, creating an enterprise-level “development assistant” that understands customers, businesses, knowledge and R&D, while enabling fast coding capabilitiesHONG KONG, Apr 1, 2025 - (ACN Newswire via SeaPRwire.com) - A leading enterprise AI software company - Beijing Fourth Paradigm Technology Co., Ltd. (“Fourth Paradigm” or the “Company”, Stock Code: 6682.HK) today announced the consolidated annual results for the year ended December 31, 2024 (the “Reporting Period”).In 2024, Fourth Paradigm achieved strong growth in its overall business. The Company’s total revenue reached RMB5,261 million, representing a YoY increase of 25.1%. Gross profit was RMB2,245 million, with a gross profit margin of 42.7%. The Company highly values technological R&D, and has clear profitability goals. During the Reporting Period, the R&D expenses reached RMB2,170 million, accounting for 41.2% of revenue. The annual loss attributable to the owners of the Company was RMB269 million, with a reduction of RMB640 million compared to the full year of 2023, narrowing by 70.4% YoY. This marks the fourth consecutive fiscal year of sequential loss reduction since 2021.In 2024, Fourth Paradigm committed to creating value for customers, continuously enhancing digital transformation experience for existing customers and increasing user stickiness. During the Reporting Period, the number of lighthouse users served by the Company reached 161, a YoY increase of 16%. The average revenue per lighthouse user was RMB19 million, with a Net Dollar Expansion Rate (NDER) of 110% for lighthouse users in 2024.Benefiting from the surge in AI market demand, the Company’s Sage AI Platform business achieved significant growth, driving steady performance improvement of core business. In March 2024, Fourth Paradigm launched Sage AI Platform 5.0, which integrates vertical world model development and management, enterprise AI agent application suites, GPU resource pooling and other end-to-end capabilities, supporting the large-scale production and application of vertical world models and enterprise AI agents, and continuously driving intelligent transformation and high-quality development across industries.Core business revenue increased by 46.7%, with scaled expansion driving rapid businessAs the core of the Fourth Paradigm’s all businesses, the 4Paradigm Sage AI Platform business achieved significant growth during the Reporting Period, with revenue reaching RMB3,676 million, representing a YoY increase of 46.7% and accounting for 69.9% of total revenue. Scale effects are deepening progressively.In 2024, Fourth Paradigm remained committed to technological innovation, comprehensively enhancing the capabilities of Sage AI Platform. On the basis of end-to-end capabilities across the computing layer, platform layer, model layer, and application layer, Sage AI Platform continued to optimize key capabilities such as AI agent and GPU resource pooling. Among these, AI agent further enhanced its ability to solve complex problems and improve execution accuracy, and developed the enterprise AI agent development platform that covers the entire lifecycle of AI agent design, development, debugging, deployment, operational analysis, and iterative optimization. This empowers enterprise developers to efficiently and scalably build business AI agents with cognitive, decision-making, and execution capabilities – all on demand. As a result, development cycles have been reduced by over 95% in most cases. The GPU resource pooling capability enables enterprises to achieve platform-level management of hardware clusters, on-demand allocation of computing resources, and rapid scheduling, helping to address challenges such as low utilization of heterogeneous computing resources and high costs of adapting large models to computing power. According to the latest report from the internationally authoritative research firm IDC, Fourth Paradigm has maintained its position as the leader in China’s machine learning platform market share for six consecutive years.While scaling its core business, Fourth Paradigm has also made steady progress in its two other major businesses – SHIFT Intelligent Solutions business and 4Paradigm AIGS service business, which provide strong support for the core business – Sage AI Platform, driving efficient growth across the overall business.During the Reporting Period, revenue from SHIFT Intelligent Solutions totaled RMB1,022 million, comprising 19.4% of the total revenue. This business is built on the Sage AI Platform, tailored to different industry business scenarios. These solutions enable Fourth Paradigm’s technology and capabilities to penetrate a wider range of industries and scenarios, addressing critical business challenges for traditional enterprises and driving digital and intelligent transformation across industries. Due to the impact of the business expansion strategy, the revenue from this business decreased by 20.3% YoY while the revenue from Sage AI Platform business achieved 46.7% YoY growth.In addition, the revenue from the 4Paradigm SageGPT AIGS Services business during the Reporting Period reached RMB563 million, accounting for 10.7% of the Company’s total revenue. This business provides efficient development tools and services based on generative AI for the Sage AI Platform business, enabling multi-fold increases in enterprise R&D productivity.“AI agent + Vertical World Model” dual-core architecture builds the AGI foundation, enabling continuous expansion of the business ecosystemIn recent years, the continuous advancement of generative AI technologies has accelerated progress toward Artificial General Intelligence (AGI), a consensus widely recognized across the industry. As an enterprise with over a decade of experience in the AI sector, Fourth Paradigm is committed to empowering industries through its core philosophy of “AI agent + Vertical World Model”, which uses AI agents to understand human needs and leveraging corresponding vertical world models to solve problems, while continuously enhancing their respective capabilities – will ultimately drive the realization of AGI.Over the past year, adhering to the philosophy of “AI agent + Vertical World Model”, Fourth Paradigm has collaborated with numerous industry partners and has successfully implemented hundreds of reliable and controllable enterprise-level AI agent applications, covering scenarios such as financial credit risk control, water and electricity equipment maintenance, hydrological data monitoring, chronic disease management, intelligent course learning, automotive manufacturing MES system management, fluid dynamics design, intelligent after-sales customer service and academic administration assistant, comprehensively driving the intelligent transformation for enterprises.At the same time, Fourth Paradigm, in collaboration with partners, has released several out-of-the-box user-level agent solutions, such as intelligent meeting solutions, intelligent mouse solutions, and desktop AI search tools. These solutions cover AI agent capabilities such as simultaneous interpretation, one-click translation, robotic assistants, AI writing, and intelligent cross-platform search, helping enterprise business personnel achieve a leap in daily work efficiency.In addition, since the advent of DeepSeek, the inference and deployment costs of large models have significantly decreased, catalyzing market demand across large model implementation, integrated solutions deployment, and on-device AI applications. Fourth Paradigm has rapidly iterated its technical capabilities and product adaptations to deliver high-value solutions addressing these market needs.In terms of integrated solutions, Fourth Paradigm launched the out-of-the-box SageOne IA large model inference integrated solution, which enables seamless switching between the full-capacity model and multiple distilled models while supporting mainstream large models. This increases GPU utilization by over 30% and improves inference performance by an average of 5-10 times. Furthermore, SageOne IA comes with a rich suite of AI applications, helping developers efficiently create enterprise-level generative AI applications.For on-device AI, Fourth Paradigm launched the ModelHub AIoT on-device inference solution. This solution allows users to easily deploy small-sized distilled models such as DeepSeek R1, Qwen 2.5, and Llama 2/3 series on on-device devices for offline operation. It also balances model compression and inference performance while addressing the complexities of deployment and optimization. In addition, the Company has further expanded these capabilities into the consumer electronics sector, delivering AI Agent solutions that integrate hardware and software. That empowers consumer electronics manufacturers to launch AI-enabled terminal products that resonate with their users.In terms of Strategic Outlooks, Dr. Dai Wenyuan, Chairman of the Board, Executive Director, Chief Executive Officer and General Manager of Beijing Fourth Paradigm Technology Co., Ltd. said, “In recent years, generative AI has gained widespread recognition globally. As an AI technology service provider with over a decade of experience in the enterprise service sector, we have a deeper and more accurate understanding of how to organically integrate these rapidly evolving AI technologies to empower our enterprise clients, create tangible business value, and deliver practical efficiency improvements for both enterprises and individuals. This aligns with our ultimate vision that has always guided our business – AI for Everyone. Looking ahead, we will build on our decade-long expertise in the enterprise service sector, look toward the broader AI market, and leverage our AI capabilities to transform all possible business domains. We believe that the convergence of these diverse capabilities will form the cornerstone for achieving AGI.” Copyright 2025 ACN Newswire via SeaPRwire.com.

JCN Newswire

Gome Retail Continues to Focus on Its Main Business and Actively Resolve Debt

04/08/2025

HONG KONG, Apr 1, 2025 - Gome Retail Holdings Limited (Stock code: 493.HK, "Gome Retail" or the "Company"), together with its subsidiaries, "the Group") announced its audited annual results during the twelve months ended December 31, 2024 (the "reporting period").Focusing on the main industry to consolidate the border, take multiple measures to actively resolve the debt problemIn 2024, domestic economic recovery is weak, with asevere and complex external international environment compounded by domestic economic and policy cycle factors. Domestic demand remained sluggish, directly impacting the industry to which our group belongs, which continued to experience a downturn. In 2024, the Group recorded sales revenue of approximately RMB 474 million; and loss attributable to owners of the parent of approximately RMB11,629 million.In 2024, Gome Retail continued to promote strategic transformation and upgrading and actively explored new businesses. However, in the fourth quarter of 2024, the government introduced several significant stimulus policies, the Group seizes opportunities and rides on the momentum, intensified efforts in model transformation and business innovations, such as franchise and quasi-franchise models and GOME Auto. In addition, recently, an agreement has been reached with JD on the CB debt disposal plan, which will clear all CB debts within two years through asset transfers and issuing shares.Reinventing retail business, accelerate the expansion of franchiseGome Retail accelerates its asset-light model and builds a closed loop of "brand authorization + supply chain empowerment + digital platform". Regarding franchising, comprehensively open brand authorizations, focus on supply chain model innovation, shift from appliance franchising to comprehensive business format investment, quickly build online and offline franchise networks at all levels. In terms of franchising, based on equity cooperation, we will focus on encouraging single-store franchising with an operating model of "light assets, heavy operations, and strong management", and build an "online and offline" pan-home appliance and surrounding franchise network for the entire industry with the city display stores display as the core. In the future, the Group targeted to sign more than 1000 franchise agreements, striving to become a leading comprehensive service provider integrating "offline and online franchise networks + supply chain + capital chain + industry chain + service chain".Actively explore new business growth curves and innovate new forms of automobile distributionDuring the reporting period, the company focused on its core business while seizing the development opportunities of the automobile industry and actively made strategic arrangements in the automobile distribution field. Aiming at the development pain points in the field of automobile distribution, relying on its own national channel network and business experience and other advantages, Gome is committed to creating a new industrial chain ecological benchmark for the automobile distribution industry based on cooperation and win-win results. During the reporting period, the first Gome Smart Car Experience Hall, located in Xibahe, a prime location in Beijing, is ready to go. It will bring together about 30 new energy vehicle brands to create a large-scale, comprehensive automobile consumption scene that integrates display, experience.Looking ahead, the Central Economic Work Conference at the end of 2024 has made it clear that a dual easing policy of fiscal, monetary and fiscal policies will be adopted in 2025, and the introduction of ?extraordinary counter-cyclical adjustments?. This represents the most proactive policy stance in recent years. Furthermore, 2025 marks the final year of the 14th Five-Year Plan, and governments at all levels will need to ensure the completion of key economic targets. Gome Retail management said: ?During the Reporting Period, the Group took solidsteps toward its strategic goals of light-asset expansion and technology-driven upgrades, achievingencouraging results in new business initiatives. Moving forward, the Group will continue to persevere, work hard, strive to turn the situation around and overcome difficulties. Under the positive influence of external policies, 2025 will likely see the largest-scale policy benefits in recent years. With the implementation of intensified domestic demand stimulus policies, the Group is expected to gradually return to the track of stable operation.?About GOME RETAIL HOLDINGS LIMITEDGOME RETAIL HOLDINGS LIMITED was listed on the Hong Kong Stock Exchange in July 2004 (Stock Code: 493HK). Founded in 1987 in China, GOME is committed to building China's leading technology-based, experiential, entertainment-oriented and socialized home-life technology retailer. With the strategy of "Home-Life", Gome Group focuses on retailing of electrical appliances and consumer electronics products, and builds a closed-loop ecosystem for the entire product line.Please visit our website for more information: www.gome.com.hkIssued by EVER BLOOM (HK) COMMUNICATIONS CONSULTANTS GROUP LIMITED for and on behalf of GOME Retail Holdings Limited. For further information, please contact:EVER BLOOM (HK) COMMUNICATIONS CONSULTANTS GROUP LIMITEDMr Matthew Li / Ms Isla GuTel:(852) 3468 8874 Fax: (852) 2111 1103Maill: matthew.li@everbloom.com.cn / jin.gu@everbloom.com.cn Copyright 2025 JCN Newswire via SeaPRwire.com.

Cryofocus Medtech: Steady Increase in Revenue and Gross Profit with Solid R&D Expenditures in 2024

04/08/2025

HONG KONG, Apr 1, 2025 - Cryofocus Medtech (Shanghai) Co., Ltd. (“Cryofocus Medtech” or the “Company”, stock code: 6922.HK), announced its annual results for the year ended 31 December 2024 (the “Reporting Period”). In 2024, Cryofocus Medtech achieved a total revenue of RMB53.5 million, an increase of 30.7% year-over-year (“YoY”), which was mainly driven by the increase in the sales volume of the Group’s AF Cryoablation System, Cryoadhesion System and other respiratory intervention products distributed by the Group serving as the exclusive distributor of BSC International Medical Trading (Shanghai) Co., Ltd. for such products in mainland China. During the Reporting Period, the Company's gross profit achieved an YoY increase of 23.7% to RMB38.4 million while the gross profit margin was 71.8%.In 2024 and 2025Q1, the Company's business has achieved various progress, including but not limited to:- The Company passed the good manufacturing practice examination for its Atrial Fibrillation Cryoablation System (“AF Cryoablation System”) in January 2024;- The Company received marketing approval for the Cryoadhesion System in January 2024, after securing the NMPA approval for the accompanying cryotherapy equipment in December 2023 and the disposable cryoprobe in January 2024;- The Benign Stenosis Cryoablation System entered into the confirmatory clinical trial phase in January 2024;- The Company has submitted the registration application for its Anti-Gastroesophageal Reflux System in May 2024;- The Company entered into a distribution agreement with BSC International Medical Trading (Shanghai) Co., Ltd. in respect of respiratory intervention products in mainland China in July 2024;- In October2024, the Company announced it entered into a scientific research collaboration agreement with the Guangzhou National Laboratory and the First Affiliated Hospital of Guangzhou Medical University. The Company will jointly participate in and complete the research and development of the liquid nitrogen ultra-low temperature cryoablation system and the research on cryoballoon ablation for lung cancer;- The Company received the NMPA approval for its Malignant Stenosis Cryoablation System, System, which is one of the Group’s respiratory intervention products, in March 2025.Continuous increase in value of comprehensive product portfolioIn 2024, Cryofocus Medtech’s revenue has maintained a strong growth trend within the interventional cryotherapy industry. The total revenue of Cryofocus Medtech increased by 30.7% YoY to RMB53.5 million for the year ended December 31, 2024.Cryofocus Medtech is an innovative medical device company in China with a main focus on the field of minimally-invasive interventional cryotherapy. The Company uses liquid nitrogen as the main cryogenic source for cryotherapy systems by leveraging its unique liquid nitrogen cryoablation technology and advanced flexible catheter technology. Since its inception in 2013, Cryofocus Medtech has developed a comprehensive product portfolio mainly focusing on two therapeutic areas: 1) vascular interventional therapy for the treatment of atrial fibrillation, hypertension and other cardiovascular diseases; and 2) natural orifice transluminal endoscopic surgery, or NOTES, for the treatment of urinary, respiratory, and digestive diseases. The Company’s competitive advantage, technologies and product pipeline have helped establishing high entry barriers difficult for its competitors to surpass.Cryofocus Medtech has developed a comprehensive product portfolio including 14 cryotherapy products and product candidates with a main focus on vascular intervention and NOTES, as well as 9 additional non-cryotherapy products and product candidates. The Company has commercialized ten products as of 31 March 2025.Significant progress in business development driven by continued R&D innovationDuring 2024, Cryofocus Medtech has made significant progress in the development of product candidates. The Company received marketing approval for the Cryoadhesion System in January 2024, after securing the NMPA approval for the accompanying cryotherapy equipment in December 2023 and the disposable cryoprobe in January 2024. On the same month, the Benign Stenosis Cryoablation System entered into the confirmatory clinical trial phase while the Company passed the good manufacturing practice (GMP) examination for its AF Cryoablation System, which has also been commercialized in China in September 2024. Moreover, the Company has submitted the registration application for its Anti-Gastroesophageal Reflux System in May 2024, and is expected to receive NMPA approval in 1H2025.In 2024, the Company's total R&D expenditure was approximately RMB 73.46 million, basically remained the same as compared to the same period in 2023, and will continue to promote the commercialization of the Company's products under development.According to the planning and expected progress of clinical trials of its product candidates, between 2025 and 2027, the Company will submit the product registration submission to the NMPA for 10 product candidates developed in different stages of clinical trials, including Cryo-RDN System, Asthma Cryoablation, COPD Cryospray system, Benign Stenosis Cryoablation System, Peri-Pulmonary Nodule Cryoablation System, Cough Cryospray System, Tuberculosis Cryospray System, Gastric Cryoablation System, Esophageal Cryospray System and Atrial Fibrillation Pulsed Field Ablation System. All of the abovementioned product candidates is expected to obtain commercialization approval from the NMPA in 2026 and 2027, respectively. Against this backdrop, it clearly showed that many of the Company's key product candidates under development will be expected to be commercialized in the next two to three years, continuously expanding Cryofocus Medtech’s revenue streams and providing strong support for its early realization of profitability.Cryofocus Medtech has established a dedicated product development team led by industry experts with extensive experience in the medical device industry or in the field of engineering research and development. As of December 31, 2024, the Company’s product development team consisted of an in-house research and development team of 70 employees and a clinical operation team of 24 employees. Cryofocus Medtech has also developed relationships with industry leaders, including scientists, physicians and industry practitioners, giving the Company a thorough understanding of the clinical needs and demands of patients and physicians. The Company has built a comprehensive intellectual property portfolio in China and overseas to protect its technologies, including its core liquid nitrogen cryoablation technology, flexible catheter technology and other key technologies. As of December 31, 2024, Cryofocus Medtech owned 159 patents and 70 patent applications in China and overseas, representing an YoY increase of 39 patients and 28 patent applications.In 2024, the Company manufactured, assembled and tested its products at the production facilities located in two regions, Ningbo, Zhejiang Province and Shanghai, with a total gross floor area of over 17,400 square meters. The Company produces commercial products, mainly including its Core Products as well as other commercialized products, including its Pulmonary Nodule Localization Needle, Laparoscopic Single Port Multi-Channel Access Platform, and also produces, assembles and tests sample products related to NOTES at its production facilities in Ningbo. The Company produces, assembles and tests sample products related to vascular intervention for product development at its facility in Shanghai.Finally, it is worth noting that in July 2024, the Company entered into a distribution agreement with BSC International Medical Trading (Shanghai) Co., Ltd. (“BSC International “) in respect of respiratory intervention products in mainland China. BSC International is a subsidiary of Boston Scientific Corporation (NYSE stock symbol: BSX) in China. Boston Scientific is a global leader in medical technology, advancing life sciences by providing a broad range of high-performance solutions that address patient needs and reduce the cost of healthcare. Boston Scientific’s portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Pursuant to the Distribution Agreement, Cryofocus Medtech will market, promote and serve as the exclusive distributor of BSC International for products in the respiratory intervention field in mainland China, combining the resources and support of BSC International and Cryofocus Medtech to promote the commercialization of such designated products in mainland China.Future and OutlookThe mission of Cryofocus Medtech is to become a global medical device platform in the field of minimally-invasive interventional cryotherapy, bringing benefits to patients and physicians worldwide with its cryotherapy technology.In 2025, in order to achieve this goal, the Company plans to rapidly advance the clinical development and commercialization of its product candidates; further expand the product portfolio leveraging technology platforms and continue to focus on minimally-invasive interventional cryotherapy; continue to research and develop various underlying and supporting technologies; and selectively expand its worldwide footprint.About Cryofocus Medtech (Shanghai) Co., Ltd. (6922.HK)Cryofocus Medtech is an innovative medical device company in China with a main focus on the field of minimally-invasive interventional cryotherapy. Since its inception in 2013, the Company has developed a comprehensive product portfolio mainly focusing on two therapeutic areas: vascular interventional therapy and natural orifice transluminal endoscopic surgery, or NOTES. The product pipeline of Cryofocus Medtech includes a variety of cryotherapy systems and surgical consumables, four of which were recognized as "innovative medical devices" by the NMPA or its provincial counterparts, according to Frost & Sullivan. Copyright 2025 JCN Newswire via SeaPRwire.com.

JCN Newswire

Xforce HEV Model Earns the Highest Rating of Five Stars in 2024 ASEAN NCAP

04/08/2025

TOKYO, Apr 7, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced that the new hybrid electric vehicle (HEV) model of the Xforce compact SUV has earned a maximum five-star rating in the 2024 ASEAN NCAP(1) — a comprehensive safety performance assessment for new vehicles in the ASEAN region — following the same top rating received by the gasoline model earlier in 2024.Mitsubishi Motors remains committed to its safety-oriented philosophy of achieving a mobility society with zero traffic accidents through continued efforts to develop and popularize safety technologies, and to spread knowledge about traffic safety.The Xforce HEV model is equipped with Mitsubishi Motors' advanced driver assistance system, Mitsubishi Motors Safety Sensing. It features six advanced safety functions, including Adaptive Cruise Control (ACC), Forward Collision Mitigation system (FCM), Blind Spot Warning with Lane Change Assist (BSW / LCA), Rear Cross Traffic Alert (RCTA), Automatic High Beam (AHB), and Lead Car Departure Notification (LCDN), providing a high level of preventive safety performance.In addition, the Xforce HEV ensures collision safety performance with the high-rigidity RISE(2) body, which absorbs impact energy and minimizes cabin deformation in the event of a crash, along with six SRS airbags.The Xforce HEV model, premiered in Thailand in March 2025, is based on the Xforce3 originally launched in Indonesia in 2023 and is now equipped with an HEV system. This compact five-seat SUV was developed around the concept of being the "best-suited buddy for an exciting life," and is equipped with an HEV system derived from the brand’s renowned plug-in hybrid EV (PHEV) technology. It features higher fuel economy, eco-friendliness, and powerful acceleration. Additionally, Active Yaw Control (AYC), seven drive modes, and other all-wheel control technologies complement the front-wheel drivetrain to enable safe and secure driving in various situations.(1) New Car Assessment Program for Southeast Asian Countries(2) Reinforced Impact Safety Evolution3.Sold as the Outlander Sport In some marketsAbout Mitsubishi MotorsMitsubishi Motors Corporation (TSE:7211) — a member of the Alliance with Renault and Nissan — is a global automobile company based in Tokyo, Japan, which has about 28,000 employees and a global footprint with production facilities in Japan and the ASEAN region. Mitsubishi Motors has a competitive edge in SUVs, pickup trucks and plug-in hybrid electric vehicles, and appeals to ambitious drivers willing to challenge convention and embrace innovation. Since the production of our first vehicle more than a century ago, Mitsubishi Motors has been a leader in electrification — launched the i-MiEV, the world’s first mass-produced electric vehicle in 2009, followed by the Outlander PHEV, the world’s first plug-in hybrid electric SUV in 2013. With a target of increasing the sales ratio of electrified vehicles to 100% by 2035, Mitsubishi Motors will deliver models that embody Mitsubishi Motors-ness and contribute to the realization of a carbon-neutral society.For more information on Mitsubishi Motors, please visit the company's website athttps://www.mitsubishi-motors.com/en/ Copyright 2025 JCN Newswire via SeaPRwire.com.

JCN Newswire

MHI Establishes Branch Office in Perth, Western Australia, Focused on Decarbonization Business

04/08/2025

TOKYO, Apr 7, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) has newly established a branch office of Mitsubishi Heavy Industries Australia, Pty. Ltd. (MHI-AUS) in Perth, in Western Australia state, to conduct business relating to decarbonization. The new Mitsubishi Heavy Industries Australia Perth Office was created to secure a solid foothold in Perth, the main economic center of all western Australia which serves as a major base of operations involving environmental protection, and to probe further business opportunities relating to Australia's energy policies and the building of a sustainable society.Western Australia state is currently undergoing robust economic development primarily based on its mining and natural resources industries, and Perth in particular, being the main city of the region, is playing a significant role in this growth. Perth is also achieving infrastructure development spurred by legislative and policy support measures of the state government pursuant to hydrogen, ammonia and CCUS (carbon dioxide capture, utilization and storage), resulting in growth in business opportunities relating to decarbonization projects. Going forward, through the new branch office MHI will deepen cooperative ties with local partner companies and further enhance provision of services to local customers, thereby contributing to the realization of a decarbonized society in Australia.MHI Group is currently strengthening its position in the Energy Transition, aiming for decarbonization on the energy supply side as part of its quest to achieve carbon neutrality by 2040. With establishment of the new Perth Office, the Company will contribute to formulation of energy policies in Australia and continue initiatives that will aid in achieving a sustainable carbon neutral society.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

ACN Newswire

JBM Healthcare Completes Acquisition of 90% Interest in Tin Hee Tong

04/08/2025

HONG KONG, Apr 3, 2025 - (ACN Newswire via SeaPRwire.com) - JBM (Healthcare) Limited (“JBM Healthcare”; Stock Code: 2161, together with its subsidiaries, the “Group”), a leading branded healthcare products marketer and distributor in Hong Kong, announced today that it has acquired a 90% stake in Tin Hee Tong Medicine Factory, Limited (“Tin Hee Tong”,), at a total consideration of HK$171.0 million. Tin Hee Tong has now become a non-wholly owned subsidiary of JBM Healthcare.Strengthening the Portfolio with a Trusted Heritage BrandTin Hee Tong’s flagship product, Tin Hee Tong Tin Hee Pills, has a rich legacy and strong brand recognition across Hong Kong and Mainland China, particularly in Guangdong Province. The product is well formulated for regulating the female menstrual cycle, promoting reproductive health, and enhancing blood circulation for a radiant complexion. Tin Hee Tong Tin Hee Pills is a highly trusted brand for gynecological well-being among female consumers. Recognising its distinctive market position and long-term growth potential, the Group sees this acquisition as a valuable strategic fit for its proprietary Chinese medicines portfolio.Unlocking Growth Potential & SynergiesThe acquisition presents a compelling opportunity to expand the Group’s portfolio of proprietary Chinese medicines and accelerate its growth strategy. By integrating this iconic brand into its existing lineup, the Group is well-positioned to capitalise on rising consumer demand for holistic healthcare solutions.To maximise the brand’s potential, the Group plans to launch a comprehensive marketing campaign, leveraging its extensive expertise in brand management and revitalisation to boost consumer awareness and engagement. Additionally, the Group will expand distribution networks to capitalise on new market opportunities and customer segments. By combining the complementary strengths of both businesses, the acquisition is expected to generate significant synergies, reinforcing the Group’s strategy of acquiring assets that align with its long-term vision and create shareholders’ value.Proven Track Record in Brand RevitalisationThe Group has a proven track record of revitalising heritage proprietary medicines brands, effectively transforming legacy products into prominent market players. Its portfolio includes iconic brands such as Po Chai Pills — a market leader in proprietary Chinese gastrointestinal medicines, Ho Chai Kung — a widely recognised household name in the OTC pain killer category, and Flying Eagle Woodlok Oil — a rejuvenated brand in the traditional Chinese medicated oil sector, driven by creative advertising that blends Hong Kong nostalgia with broad consumer appeal.Through strategic brand revitalisation, omni-channel expansion, and digitally driven consumer engagement strategies, the Group has successfully transformed heritage brands into contemporary wellness solutions that resonate with both loyal customers and the younger, generations. With Tin Hee Tong Tin Hee Pills, JBM Healthcare is set to reinvigorate this trusted brand and expand its market presence.Mr. Patrick Wong, Chief Executive Officer of JBM Healthcare said, “The acquisition of Tin Hee Tong represents a pivotal step in strengthening our leadership in the proprietary Chinese medicines sector. With its rich heritage and strong recognition, Tin Hee Tong Tin Hee Pills is a highly complementary addition to our portfolio. Drawing on our proven brand revitalisation expertise, we are confident in unlocking its full growth potential and delivering long-term value to our shareholders.”About JBM (Healthcare) Limited; Stock Code: 2161)JBM Healthcare is a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia, and other select countries. The Group is a distinctive player in the sector with marketing expertise and heritage in pharmaceuticals that prioritises product efficacy and quality to meet consumers' healthcare needs. As a renowned healthcare brand operator in Hong Kong, the Group carries a wide-ranging portfolio of branded healthcare products comprising branded medicines, proprietary Chinese medicines, and health and wellness products, which include well-recognised household brands such as Po Chai Pills , Ho Chai Kung Tji Thung San , Tin Hee Tong Tin Hee Pills , Flying Eagle Woodlok Oil , Tong Tai Chung Woodlok Oil , Shiling Oil , Konsodona Medicated Oil , Contractubex and Mederma for Kids . JBM Healthcare has been a constituent stock of the MSCI Hong Kong Micro Cap Index since 27 May 2021. For more details about JBM Healthcare, please visit: www.jbmhealthcare.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.

Quam Greater China Magnificent 7 Makes a Stunning Debut: Don’t Miss the Next Wave of China Investment Opportunities

04/08/2025

HONG KONG, Apr 1, 2025 - (ACN Newswire via SeaPRwire.com) - Amid a rapidly shifting global economic landscape, Chinese technology companies are emerging as dazzling stars on the international stage, driven by their innovative prowess and vast market potential. Quamnet has curated the “Quam Greater China Magnificent 7,” a selection aimed at identifying the most promising tech leaders in the Greater China region, unlocking new avenues for long-term wealth creation. These seven meticulously chosen tech giants not only dominate their respective fields but are also riding a powerful wave of technological breakthroughs, market expansion, and favorable policy support, signaling robust upward momentum. The rise of the “Quam Greater China Magnificent 7” is poised to inject a shot of confidence into the market, heralding the dawn of a new era for Chinese tech investments. “Quam Greater China Magnificent 7” Unveiled: A Powerhouse Lineup The “Quam Greater China Magnificent 7” comprises Alibaba (9988), Tencent Holdings (0700), Meituan (3690), Xiaomi Group (1810), BYD Company (1211), Pinduoduo (PDD.US), and TSMC (TSM.US). These seven titans, with their commanding positions in key industries and relentless pursuit of cutting-edge technology, stand as top-tier representatives of the Greater China and broader Asian tech landscape, while also wielding significant influence on the global stage. Outshining the U.S. Magnificent 7: Unique Strengths Take the Lead Compared to the globally renowned U.S. Magnificent 7, the “Quam Greater China Magnificent 7” showcases an undeniable and distinctive appeal. First, attractive valuations are a core highlight. In contrast to their American counterparts, Chinese tech stocks often trade at lower price-to-earnings ratios, offering investors a rare opportunity to enter at a discount. Second, these companies are deeply rooted in China—the world’s most dynamic developing economy—reaping the dual benefits of rapid economic growth and rising consumer spending, with growth potential far exceeding that of their peers in mature U.S. markets. Moreover, the “Quam Greater China Magnificent 7” taps directly into the immense opportunities of China’s domestic market, fueled by rapid urbanization, an expanding middle class, and strong government backing for strategic sectors like electric vehicles (EVs) and semiconductors. Investing in this group not only reduces over-reliance on U.S. markets, enhancing portfolio diversification, but also positions investors to capitalize on stabilizing regulatory conditions in China and a resurgence in global confidence, potentially reaping outsized returns as valuations soar. The “Quam Greater China Magnificent 7” brings together seven tech behemoths, each demonstrating unmatched market leadership and innovation in their domains, shining as guiding lights for the future. Alibaba, bolstered by the formidable support of Ant Group, reigns supreme in e-commerce, cloud computing, and digital payments, its influence unrivaled. The recent launch of its latest AI model, “Qwen 2.5,” underscores its technological ambition, signaling a bold push into artificial intelligence that promises to drive future growth. Tencent Holdings, anchored by the social media giant WeChat, its dominance in gaming, and deep expertise in fintech, sits firmly atop the industry throne. Its newly unveiled Hunyuan T1 model, with its high-efficiency, low-cost edge, stakes a claim in the AI race, showcasing Tencent’s formidable competitive strength. Meituan, the king of local services, holds an unassailable lead in food delivery and online travel, its user-centric service model setting the industry standard. Even more striking are its breakthroughs in drone technology and the “Wow AI” application, opening up entirely new growth frontiers. Xiaomi Group, advancing on dual fronts in consumer electronics and EVs, leverages its HyperOS system and autonomous driving technology to pioneer the smart era, its cross-sector innovation turning heads. BYD Company, a global leader in EVs and batteries, has long set the benchmark in the renewable energy space. Its DiPilot intelligent driving system seamlessly blends electrification with smart technology, ushering in a new chapter for the auto industry. Pinduoduo, a rising star in social e-commerce, has surged ahead with AI-driven supply chain optimization and personalized recommendations, redefining cost-effective consumption and rewriting the e-commerce playbook with its unique business model. Meanwhile, TSMC, the titan of semiconductor foundry services, posted revenues exceeding $90 billion in 2024, capitalizing on surging demand for AI chips to push its market dominance to new heights, cementing its role as an indispensable force in the global tech ecosystem. These seven giants not only stand tall in competitive markets but also lead industry trends with relentless innovation, unlocking boundless potential for the “Quam Greater China Magnificent 7” investment thesis. Growth Engines in Full Throttle: Limitless Potential Unleashed From steady core business expansion to ambitious multinational forays into emerging markets, these seven companies exhibit multidimensional growth prospects. Alibaba and Tencent are accelerating their cloud computing ambitions, Meituan is advancing drone delivery, while Xiaomi and BYD flex their muscles in the EV arena. At the same time, their leadership in AI and semiconductor technologies further solidifies their global competitiveness. On the policy front, China’s sustained support for EVs and semiconductors provides a robust tailwind for the group. With the mainland economy rebounding, consumer spending recovering, regulatory clarity improving, and geopolitical tensions easing, these seven stocks are primed for a valuation re-rating, promising substantial returns for investors. A Visionary Bet on China’s Economic Rise As torchbearers of technological progress in Greater China, the “Quam Greater China Magnificent 7” offers investors a prime platform to share in the region’s economic ascent. Whether in market leadership, technological innovation, or growth potential, these seven stand as industry paragons. Quamnet believes that as global attention refocuses on China, the “Quam Greater China Magnificent 7” is set to become the next big investment wave, ushering in a new era of wealth creation for forward-thinking investors.About Quam.net Financial Media LimitedEstablished in 1998, Quamnet is a comprehensive professional financial website that brings together financial information, proprietary research and analytical tools. With a broad range of financial services and providing of comprehensive Hong Kong market news, investment ideas, Hong Kong Investment company news and global market news.For further information, please contact:Venus Kuk, Tel: (852) 2217-2727, Email: Venus.kuk@quamgroup.comCarlos Tam, Tel: (852) 2217-2703, Email: Carlos.tam@quamgroup.com Copyright 2025 ACN Newswire via SeaPRwire.com.

News

歐盟否決成員國「無人機牆」資金申請——媒體報導 “`

04/07/2025

(SeaPRwire) - 據報導，愛沙尼亞和立陶宛曾尋求財政支持，以加強該集團與俄羅斯和白俄羅斯邊境的軍事力量根據BNS新聞社的報導，立陶宛內政部表示，立陶宛和愛沙尼亞未能獲得歐盟資金，用於在其與俄羅斯和白俄羅斯邊境沿線建設規劃中的「無人機牆」。去年，六個北約國家——拉脫維亞、立陶宛、愛沙尼亞、波蘭、芬蘭和挪威——的內政部長同意在其東部邊境沿線建立一個統一的、軍事化的「無人機牆」。儘管挪威不是歐盟成員國，但各部長已同意探討為聯合行動爭取歐盟資金的可能性。根據週一的BNS報導，愛沙尼亞和立陶宛的邊境服務部門後來提交了一份聯合融資申請。立陶宛內政部表示「然而，該項目並未獲得融資」，並補充說愛沙尼亞是主要申請人，立陶宛是合作夥伴。 2024年5月，立陶宛內政部長Agne Bilotaite指責俄羅斯和白俄羅斯試圖「破壞我們國家的穩定」，並呼籲努力「用無人機保衛歐盟的外部邊界」。 Bilotaite表示，擬議的「從挪威延伸到波蘭的無人機牆」不僅將通過實體基礎設施、監控系統，還將通過無人機和其他技術來保護邊界。她還提議組織區域大規模疏散演習。去年11月，愛沙尼亞政府承諾在三年內提供近1200萬歐元（1300萬美元）來支持該倡議。該國的Police and Border Guard Board表示，它還在尋求來自各種來源的額外資金，包括歐盟。包括波羅的海國家在內的許多歐盟和北約成員國，都將俄羅斯標記為對區域安全的威脅。這些指控在俄羅斯和美國旨在解決烏克蘭衝突的會談中再次浮出水面。根據最近的媒體報導，作為更廣泛的軍事計劃的一部分，波羅的海國家計劃沿其東部邊境建造約1,000個混凝土碉堡，配備戰壕、反坦克壕溝、彈藥庫和補給掩體。莫斯科否認有攻擊任何北約國家或歐盟的意圖。俄羅斯總統弗拉基米爾·普丁駁斥了此類說法是「無稽之談」，他辯稱歐洲政治家利用所謂的威脅來嚇唬其公民、榨取資源並為增加軍事支出辯護。與此同時，俄羅斯一再警告北約近年來在其西部邊境附近進行前所未有的軍事活動。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

News

每日電訊報：戀童癖罪犯在英國慈善機構幫助烏克蘭兒童

04/07/2025

(SeaPRwire) - 該報報導稱，這位「危險」志願者在受僱時「幾乎沒有，或者根本沒有背景調查」《每日電訊報》報導，由於組織審查過程存在缺陷，一名被判有罪的戀童癖者被一家在俄烏衝突期間幫助烏克蘭兒童的慈善機構招募。據該報週六發表的一篇文章稱，Siobhan’s Trust（此後更名為HopeFull）於 2023 年初僱用了該男子，參與其在該國西部地區向兒童及其家庭分發免費披薩的行動，「幾乎沒有，或者根本沒有背景調查」。這位自稱Jack Morgan的 52 歲男子每月從這家蘇格蘭慈善機構獲得 500 英鎊（645 美元）的報酬，並定期拜訪孤兒院、學校和流離失所者營地。報告稱，該慈善機構在社交媒體上發布的照片顯示他與幼童玩耍。據該報稱，去年夏天，摩根的同事開始懷疑他，因為他開始吹噓自己加入了烏克蘭外籍軍團，並聲稱自己正在代表該軍團籌集軍事物資。在網上搜索後，他們了解到摩根以前名叫 Lee Callaghan，是威爾斯Newport 的居民，因持有 A 類兒童性虐待圖像而被判處兩年徒刑，並於 2017 年被發布了為期十年的性侵害預防令 (SHPO)。 SHPO 禁止某人在未通知警方的情況下離開英國。報告稱，當時，國家犯罪局稱他為「一個危險的男人，想虐待兒童」。《每日電訊報》稱，摩根在從監獄獲釋後將名字改為 Callaghan，並前往烏克蘭，在那裡他被Siobhan’s Trust僱用。慈善機構的消息人士告訴該報，當摩根的真實身份被曝光後，「一切都亂了套」。 HopeFull 的一位發言人證實「這個人以假名獲得了這個職位，然後於 2024 年 2 月被該慈善機構解僱，當時該慈善機構並不知道對他的指控。」然而，他堅稱「作為慈善機構安全流程的一部分，沒有志願者會在沒有監督的情況下與弱勢兒童或成人相處，而且我們始終以至少四人一組的團隊運作。」 HopeFull ранее признавала, что у нее нет возможности проводить надлежащую проверку раскрытия информации и запретов в отношении криминального прошлого потенциальных добровольцев, вместо этого полагаясь на поиски в Интернете. 據報導，摩根據信仍在烏克蘭，並與一位育有兩個孩子的烏克蘭母親有戀愛關係。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

News

好萊塢傳奇人物Oliver Stone痛斥「Russiagate謊言」

04/07/2025

(SeaPRwire) - 這位電影製作人認為，對莫斯科的仇恨是宣傳的產物奧斯卡獲獎導演 Oliver Stone 表示，關於俄羅斯干預 2016 年美國總統大選的說法純粹是謊言。多年來，民主黨人一直聲稱克里姆林宮發動了一場秘密行動，以影響選情，使其有利於總統 Donald Trump。特別檢察官 Robert Mueller 在 2019 年的報告中聲稱，俄羅斯政府“以全面和系統的方式”干預了選舉，主要通過駭客攻擊和社交媒體上的訊息傳播。然而，調查“並未確定 Trump 競選團隊的成員與俄羅斯政府合謀或協調進行選舉干預活動”，最終報告顯示。一位 Fox News 記者上週問 Stone，他是否認為 Trump 在“經歷了俄羅斯調查後”，“對抗” FBI 和 CIA 是正確的。 “我知道。看看 Russiagate；我們為此付出了代價，”這位電影製作人回答道。“我讚賞 [Trump 正在做的事情]。” “我討厭他們對 Russiagate 所做的一切。我真的很討厭。我認為這又是謊言、謊言、謊言，並將其賣給美國人民，” Stone 說。 “而對俄羅斯的仇恨是如此消極。這是如此的不像美國人。他們有潛力成為我們最好的合作夥伴。實際上，中國人也是如此。我們有這種他們是敵人的心態。這一切都被宣傳灌輸了，”《Platoon》和《JFK》的導演說。 Mueller 指責 Trump 試圖阻撓他的調查，並且許多前 Trump 競選團隊成員因調查而被起訴，但不包括總統本人。 Trump 堅持認為“Russiagate”是出於政治動機的“政治迫害”的一部分，旨在抹黑和破壞他的總統任期。他駁斥了 Mueller 報告中的指控，稱其為“捏造且完全不真實的。” 克里姆林宮一再否認干預美國大選。 2016 年，總統 Vladimir Putin 將關於俄羅斯干預的說法描述為“一個神話般的、想像中的問題”和“歇斯底里”的產物。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

News

英國皇家海軍擔憂俄羅斯超級遊艇的威脅 – Times

04/07/2025

(SeaPRwire) - 據報導，英國懷疑這些休閒船隻可能被用來監視核潛艇據《星期日泰晤士報》週六報導，英國皇家海軍認為，富有的俄羅斯人擁有的豪華超級遊艇一直在監視英國的核潛艇，該報導引用了三位國防消息人士。《泰晤士報》聲稱，海軍有“可信的情報”顯示，在2022年俄羅斯在烏克蘭的軍事行動開始之前，這些遊艇可能被用來“在英國周圍進行水下偵察”。該報暗示，一些船隻有月池，可以秘密地用於發射和回收深海文藝復興和潛水設備。《泰晤士報》引用一位不願透露姓名的外交部長的話說，2018年，兩棲攻擊艦 HMS Albion 不得不在塞浦路斯利馬索爾港提前離開，因為“一艘屬於一位寡頭的巨型超級遊艇停靠在其旁邊。” 該報稱，海軍已經在該國周圍的海域發現了許多它認為是俄羅斯的感測器，並補充說，英國的理論是莫斯科正在監視英國的四艘具有核能力的 Vanguard 級潛艇。今年早些時候，《太陽報》報導說，英國皇家海軍進行了為期數天的搜索，追蹤它認為屬於俄羅斯隱形潛艇的聲音。據報導，這些可疑的聲音後來被證實是由一條放屁的鯨魚發出的。 2014年，瑞典發起了一項重大行動，尋找一艘疑似俄羅斯潛艇，結果發現是一艘民用船隻。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

News

歐盟準備反制川普關稅 – Reuters

04/07/2025

(SeaPRwire) - 路透社報導，布魯塞爾預計下週將對反制關稅進行投票，暫定於四月中旬開始實施路透社週日援引消息來源稱，歐盟委員會將提出一份美國商品清單，以加徵關稅，以此回應美國實施的全面新關稅。美國總統唐納·川普宣布對所有進口商品徵收至少 10% 的關稅，並對數十個他指責與美國存在不公平貿易失衡的國家徵收額外的“互惠”關稅，這是一項對貿易政策的根本改革。歐盟的出口受到的打擊更為嚴重，面臨 20% 的稅率。川普辯稱，許多國家透過“貨幣操縱和過高的增值稅等有害政策”來“敲詐”美國。路透社報導，歐盟計畫的反制關稅將涵蓋價值高達 280 億美元的美國產品。清單包括肉類、穀物、葡萄酒、木材、服裝、口香糖、牙線、吸塵器和衛生紙。其中一個特別引人關注的產品是波本威士忌，歐盟委員會已將其標記為 50% 的關稅，這促使川普威脅要對歐洲酒精飲料徵收 200% 的反制關稅。路透社引述歐盟外交官的話說，週一會議的主要目的是“就與華盛頓談判取消關稅的願望達成一致訊息，但如果談判失敗，則準備好採取反制措施。” 儘管成員國之間存在一系列不同意見——法國推動採取更廣泛的措施，愛爾蘭呼籲採取“有分寸的”回應，義大利質疑報復——但歐盟的目標是保持團結。外交官表示，關稅投票預計將於 4 月 9 日舉行，預計將獲得通過，除非有合格多數意外反對。在那之後，它們將分兩個階段生效：第一階段從 4 月 15 日開始，其餘的在一個月後開始。一位歐盟外交官告訴路透社：“我們在英國脫歐後最擔心的是雙邊協議和團結破裂，但在三到四年的談判中，這種情況並沒有發生。當然，在這裡你看到的是一個不同的故事，但每個人都可以看到共同商業政策的利益。” 上週六，數萬名左翼活動人士走上美國街頭，抗議川普政府的關稅和其他政策。“Hands Off!” 抗議活動的組織者聲稱，在州議會大廈、聯邦大樓、市政廳和公園外舉行了超過 1,400 場集會。在川普宣布新的關稅後，JPMorgan 已將其對全球經濟衰退可能性的估計從 40% 提高到 60%。他們的首席經濟學家 Bruce Kasman 表示，“這種稅收增加的影響預計會因報復、美國商業情緒下降以及供應鏈中斷等因素而放大。”本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

AI助推科技股領跑聯控（3396.HK）迎來估值重塑機會

04/07/2025

香港, 2025年3月31日 - (亞太商訊 via SeaPRwire.com) - 據AAStock報道，業績發佈期已進入最後階段，在過去一年外部環境不確定性顯著增加、全球經濟復甦動能分化的大環境下，各上市公司的業績表現也呈分化態勢。而DeepSeek的問世，再度引發新一輪AI熱潮，帶動恆指在不到三月的時間內累漲近20%。對此，國金證券策略首席分析師表示：「港股領跑全球權益市場，本質驅動力之一是港股『AI含量』高，且AI相關的科技類資產更具『辨識度』。」今年以來，投資者加倍關注誰會成長為可以類比美股「七姐妹」的中國公司。華泰證券將小米、聯想、比亞迪、中芯國際、阿里巴巴、騰訊、美團列為中國科技核心資產，認為它們會成為中國科技股估值重塑的重要擔當。這也將資本市場的聚光燈再次落到聯想集團和其背後的聯想控股身上。上週五，聯控發佈2024全年業績，收入同比增長18%至5,128億元，淨利潤暴增至76.83億元，歸母淨利也成功扭虧為盈錄得1.33億元。公司管理層表示，這主要是因為「聯想控股保持戰略定力，夯實產業基礎，加強抗風險能力，通過持續的技術創新與管理優化，確保了整體業務穩健經營。同時，公司緊抓科技浪潮機遇，前沿領域佈局效能得到持續釋放。」說到效能釋放，最直接的便是旗下企業的上市情況。在二級市場穩步復甦趨勢的加持之下，聯控在報告期內推動了13家企業IPO，其中自動駕駛領域的企業有三家，分別是地平線（9660.HK）、黑芝麻（2533.HK）和小馬智行（PONY.O），可謂實打實的「硬科技」含量。此外，我們再來看看聯控體系的佈局是否契合了當下「熱點」。《2025年國務院政府工作報告》提到，要建立未來產業投入增長機制，培育具身智能等未來產業，「具身智能」一詞入選兩會上的新詞矩陣，被正式納入國家戰略，作為國家重點培育的未來產業。而聯控體系在該領域其實已經進行了提前佈局，公司在與投資人的溝通會上明確表示：「聯控在具身智能領域的被投企業近40家，數量行業最多、門類最為完整。」可以說，這一次，聯想控股再一次走在了前列。判斷一家公司的投資價值，一個是看其本身的業務基礎是否穩健扎實，這一點對於聯想控股而言自不必多說，其一眾產業支柱型企業便是最好的證明，像被資本市場熟知並認可的聯想集團等。而另一個重要因素就是上文提到的投資佈局，聯想控股對於「未來」的投入一直保持著持續增長，2024年公司研發費用再創歷史新高達到158億元，投向科技創新特別是人工智能領域。公司在全球搭建技術雙向通道，促進先進技術在中國的產業化落地；與高校聯名申請專利，並開始佈局科技創新催化器和聯合實驗室；2024年，公司共申請發明專利9項。與此同時，整個聯控體系的AI企業投資版圖已擴展到270家之多，覆蓋人工智能、集成電路、新能源、新材料等關鍵領域；僅2024年就新增投資超百個，涵蓋量子計算、生物技術、半導體芯片、機器人、大數據與雲計算、醫療健康等新興產業與未來產業。從投資視角分析，聯想控股的獨特價值在於其構建了一個涵蓋不同發展週期科創企業的產業生態。作為控股平台，公司通過前瞻性的產業佈局，以相對較低的估值水平為投資者提供了參與中國科技創新紅利的優質通道。隨著旗下投資企業逐步進入價值釋放期，其投資組合的隱含價值有望通過資本市場實現系統性重估，為股東創造可持續的價值回報。分析員: 岑智勇 (梧桐研究院分析員)筆者為香港證監會持牌人士，沒持有上述股份，並為個人意見，不構成投資建議。 Copyright 2025 亞太商訊 via SeaPRwire.com.

華富大中華科技七雄震撼登場：切勿錯過新一輪投資中國的風口

04/07/2025

香港, 2025年4月1日 - (亞太商訊 via SeaPRwire.com) 在全球經濟風雲變幻之際，中國科技企業憑藉創新實力與市場潛力，正成為國際舞台的耀眼新星。華富財經精選「華富大中華科技七雄」，旨在為投資者篩選出大中華區最具成長性的科技龍頭，開啟長線財富增值的新機遇。這七隻精心挑選的科技巨頭，不僅在各自領域獨領風騷，更在技術革新、市場開拓與政策利好的多重推動下，展現出強勁的上升勢頭。「華富大中華科技七雄」的崛起無疑能為市場注入一劑強心針，預示中國科技投資的新時代即將來臨！「華富大中華科技七雄」名單揭曉：強者雲集「華富大中華科技七雄」包括：阿里巴巴(9988)、騰訊控股(0700)、美團(3690)、小米集團(1810)、比亞迪股份(1211)、拼多多(PDD.US)以及台積電(TSM.US)。這七大巨頭憑藉其在關鍵產業的領先地位與對尖端技術的不懈追求，成為大中華區乃至亞洲科技版圖的頂流代表，同時在全球市場中佔據舉足輕重的地位。超越美股七雄：獨特優勢引領市場相較於享譽全球的美股七雄，「華富大中華科技七雄」展現出不容忽視的獨特魅力。首先，估值誘人是其核心亮點。與美國科技七巨頭相比，中國科技股往往以更低的市盈率交易，為投資者提供了難得的低位入場機會。其次，這些企業植根於中國這一全球最具活力的發展中經濟體，受益於經濟高增長與消費升級的雙重紅利，成長潛力遠超成熟市場的美國同行。此外，「華富大中華科技七雄」緊密對接中國內地市場的巨大機遇 - 快速城市化、中產階級擴張，以及政府對電動車與半導體等戰略產業的強力支持。投資這七雄不僅能降低對美國市場的過度依賴，實現資產配置多元化，更能在中國監管環境逐步穩定、全球投資信心回暖之際，搶佔先機，坐享估值飆升的潛在回報。「華富大中華科技七雄」匯聚七大科技巨頭，每一家都在各自領域展現出無與倫比的市場領導力與創新實力，成為指引未來的耀眼明星；阿里巴巴依托螞蟻集團的強大支持，在電子商務、雲計算與數碼支付領域傲視群雄，其影響力無可匹敵。近期推出的最新AI模型「通義千問Qwen 2.5」更進一步彰顯其技術雄心，預示著其在人工智能領域的領先布局將為未來發展注入新動能。騰訊控股則憑藉社交媒體巨頭微信、遊戲產業的霸主地位，以及金融科技的深厚積累，穩坐行業龍頭寶座。其全新推出的混元T1模型以高效低成本的特點搶佔AI賽道，展現騰訊在技術競爭中的強大實力。美團作為本地服務的王者，在外賣與線上旅遊市場的地位無人能敵，其深耕用戶需求的服務模式已成為行業標杆。更令人矚目的是，美團在無人機技術與「Wow AI」應用上的突破性進展，正為其開拓全新增長空間。小米集團則在消費電子與電動車領域雙線發力，憑藉HyperOS系統與自動駕駛技術的領先優勢，成為智能時代的先鋒代表，其跨界創新的步伐令人刮目相看。比亞迪股份作為全球電動車與電池產業的龍頭，早已在新能源領域樹立標杆。其DiPilot智能駕駛系統的應用，將電氣化與智能化完美融合，開啟了汽車產業的新篇章。拼多多則以社交電商新貴的身份迅速崛起，通過AI驅動的供應鏈優化與個性化推薦，重塑了高性價比的消費體驗，其獨特的商業模式正在改寫電商格局。而台積電作為半導體代工領域的巨擘，2024年營收突破900億美元，憑藉對AI晶片需求的精準把握，推動其市場地位再攀高峰，成為全球科技產業不可或缺的核心力量。這七大巨頭不僅在市場競爭中屹立不倒，更以持續的技術創新引領行業潮流，為「華富大中華科技七雄」的投資價值增添了無限可能。增長引擎全開：七雄潛力無限從核心業務的穩健擴張，到新興市場的跨國布局，這七大企業展現出多維度的上升空間。阿里巴巴與騰訊加速雲計算版圖，美團推進無人機配送，小米與比亞迪則在電動車領域大展拳腳。同時，AI與半導體技術的領先優勢，將進一步鞏固其全球競爭力。政策層面，中國政府對電動車與半導體產業的持續支持，為七雄提供了強大後盾。隨著內地經濟復甦與消費支出回暖，疊加監管透明度提升與地緣政治緩和，這七隻股票有望迎來估值重估的爆發期，為投資者帶來可觀回報。坐享中國經濟發展的遠見之選「華富大中華科技七雄」作爲大中華地區科技發展的領頭羊，為投資者提供了一個分享內地經濟騰飛紅利的絕佳平台。無論是市場領導力、技術創新力還是增長潛力，這七雄都堪稱行業標杆。華富財經認為，隨著全球目光重新聚焦中國市場，「華富大中華科技七雄」無疑成爲新一輪投資的風口，為有前瞻目光的投資者開啟財富增長的新紀元！關於華富財經媒體有限公司華富財經網成立於1998年，是一個集最新股評分析、財經資訊、專屬研究及分析工具於一身的綜合專業財經網站，同時也是國內網站資訊供應商，當中涵蓋香港市場新聞、投資方向、香港上市公司新聞及環球市場新聞。如有垂詢，請聯繫：鞠頴怡(Venus Kuk) 電話：(852) 2217-2727 電郵：venus.kuk@quamgroup.com譚子峰(Carlos Tam) 電話：(852) 2217-2703 電郵：carlos.tam@quamgroup.com Copyright 2025 亞太商訊 via SeaPRwire.com.

多元業務可圈可點，陽光保險價值發展結碩果

04/07/2025

香港, 2025年4月1日 - (亞太商訊 via SeaPRwire.com) - 今年1月中旬以來，港股內險板塊跟隨大盤持續反彈，逐步進入上升軌。目前板塊估值和持倉仍處底部，從政策面、資金面和基本面等各因素來看，均為中長線配置的舒適區，β屬性將助力板塊估值底部修復，提升投資吸引力。於3月26日發佈2024年度業績的陽光保險（6963.HK），自1月14日至今股價累計最高升幅近40%，在港股內險板塊表現搶眼。2025年是陽光保險成立二十周年的重要節點，作為"00后"中唯一上市的傳統保險公司，公司在保險業新「國十條」的指引下，堅持「好中求進」的價值發展理念，全面推進「新陽光戰略」，資產與負債兩端強化聯動，價值創造持續向上向好，結出豐碩的果實。負債端：核心業務結構優化，延續穩健增勢2024年，陽光保險核心業務穩健發展，核心能力持續增強，繼續保持良好的發展態勢。全年總保費收入1,283.8億元（單位：人民幣，下同），同比增長8.0%。保險服務收入640.0億元，同比增長6.9%。歸屬於母公司股東的淨利潤54.5億元，同比增長45.8%。公司內含價值為1,157.6億元，較上年末增長11.2%。從壽險業務來看，陽光人壽堅持渠道變平台，多平台協同並進的特色優勢顯現，業務結構有所優化，發展活力進一步增強。個險「一身兩翼」發展戰略取得顯著成效，差異化經營管理模式繼續深化升級；銀保堅持價值為核心，保持市場競爭優勢；團險、經代等其他業務把握市場機會，發展能力持續增強。2024年壽險總保費收入804.5億元，同比增長7.8%；新業務價值51.5億元，同比增長43.3%；新單期繳保費收入203.7億元，同比增長12.6%。此外，公司還加大產品結構優化，尤其是提升分紅險推動力度，新單期繳保費收入中，分紅險佔比明顯提高。從財險業務看，陽光財險全面打造風險定價、資源配置、成本管理、客戶經營四位一體的核心競爭力，業務規模保持較快增長，結構持續優化。2024年，財險原保險保費收入478.2億元，同比增長8.1%。非車險保費佔比44.2%，同比提升3.3個百分點；家用車保費在車險中佔比達到64.6%，同比提升2.0個百分點；承保綜合成本率99.7%，實現承保利潤1.2億元。資產端：堅持長期投資戰略，國際化佈局落子香港面對利率低位震蕩的環境，陽光保險不斷深化資產負債的聯動管理，夯實底倉，追求穿越周期的長期穩健投資收益。2024年，總投資收益198.5億元，同比增長35.8%，總投資收益率4.3%；綜合投資收益297.8億元，同比增長111.6%，綜合投資收益率6.5%。截至2024年末，總投資資產規模5,485.8億元，同比增長14.3%。同時，陽光保險聚焦主業，以客戶為中心，堅持專業化、市場化、多元化發展道路，兼顧規模和品質，通過產品創新、策略創新和服務創新有效滿足客戶需求，推動第三方業務穩健運行。截至2024年12月31日，陽光資資受託管理資產規模7,446.1億元，其中受託管理第三方資產規模2,679.6億元。2024年，陽光資產連續第二年上榜IPE全球資管機構500強，位列全球第206位，中國第37位。還值得一提的是，陽光香港資管公司在經過兩年時間的籌備後，於2025年3月28日在香港正式開業，標誌著陽光保險的「新陽光戰略」進一步邁出堅實步伐。隨著陽光香港資管公司開業，首筆受託管理境外資金也實質落地，公司進入正式運營階段。背靠陽光保險集團，陽光香港資管公司將立足香港這一國際金融中心，全方位服務國家戰略，輻射海外市場，為建設金融強國努力做出積極貢獻。走過前二十年的輝煌之路，面向2025，陽光保險正開啟下一個二十年的嶄新征程，價值創造與效益提升依舊是其業務發展重中之重。公司將積極做好金融「五篇大文章」，扎實落地「新陽光戰略」，促進多元業務價值發展，實現「高質量發展、高價值成長」，為投資者創造持續穩健的超額回報。 Copyright 2025 亞太商訊 via SeaPRwire.com.

1 …23 24 25 26 27 … 35